ISIN | CH1416135346 |
---|---|
Valor Number | 141613534 |
Bloomberg Global ID | |
Fund Name | UBS ETF (CH) - SPI® ESG CHF dis |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | n/a |
Peculiarities |
Current Price * | 3.41 CHF | 13.05.2025 |
---|---|---|
Previous Price * | 3.41 CHF | 12.05.2025 |
52 Week High * | 3.54 CHF | 21.03.2025 |
52 Week Low * | 2.98 CHF | 09.04.2025 |
NAV * | 3.41 CHF | 13.05.2025 |
Issue Price * | 3.41 CHF | 13.05.2025 |
Redemption Price * | 3.41 CHF | 13.05.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,601,649,191 | |
Unit/Share Assets *** | 474,552 | |
Trading Information SIX |
YTD Performance | - | - |
---|---|---|
1 month | +7.73% |
14.04.2025 - 13.05.2025
14.04.2025 13.05.2025 |
3 months | -3.68% |
21.03.2025 - 13.05.2025
21.03.2025 13.05.2025 |
6 months | - | - |
1 year | - | - |
2 years | - | - |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 12.35% | |
---|---|---|
Novartis AG Registered Shares | 11.84% | |
Nestle SA | 10.56% | |
Zurich Insurance Group AG | 6.39% | |
ABB Ltd | 5.35% | |
Compagnie Financiere Richemont SA Class A | 5.05% | |
UBS Group AG | 3.73% | |
Swiss Re AG | 3.28% | |
Holcim Ltd | 2.81% | |
Givaudan SA | 2.72% | |
Last data update | 05.05.2025 |
TER | 0.12% |
---|---|
TER date | 20.03.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.12% |
Ongoing Charges *** | 0.12% |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |